170 related articles for article (PubMed ID: 6291750)
21. T1653 mutation in the box alpha increases the risk of hepatocellular carcinoma in patients with chronic hepatitis B virus genotype C infection.
Ito K; Tanaka Y; Orito E; Sugiyama M; Fujiwara K; Sugauchi F; Kato T; Tokita H; Izumi N; Kato M; Yuen MF; Lai CL; Gish RG; Ueda R; Mizokami M
Clin Infect Dis; 2006 Jan; 42(1):1-7. PubMed ID: 16323084
[TBL] [Abstract][Full Text] [Related]
22. Hepatitis B and C viruses in hepatitis B surface antigen negative hepatocellular carcinoma patients.
Bréchot C; Minami M; De Mitri S; Paterlini P
Princess Takamatsu Symp; 1995; 25():199-209. PubMed ID: 8875625
[TBL] [Abstract][Full Text] [Related]
23. Epidemiology of hepatocellular carcinoma. Evaluation of viral and other risk factors in a low-endemic area for hepatitis B and C.
Peters M; Wellek S; Dienes HP; Junginger T; Meyer J; Meyer Zum Büschendfelde KH; Gerken G
Z Gastroenterol; 1994 Mar; 32(3):146-51. PubMed ID: 8197809
[TBL] [Abstract][Full Text] [Related]
24. Correlations of chronic hepatitis B virus infection and cigarette smoking with elevated expression of neu oncoprotein in the development of hepatocellular carcinoma.
Yu MW; Chen CJ; Luo JC; Brandt-Rauf PW; Carney WP; Santella RM
Cancer Res; 1994 Oct; 54(19):5106-10. PubMed ID: 7923126
[TBL] [Abstract][Full Text] [Related]
25. Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis.
Ioannou GN; Splan MF; Weiss NS; McDonald GB; Beretta L; Lee SP
Clin Gastroenterol Hepatol; 2007 Aug; 5(8):938-45, 945.e1-4. PubMed ID: 17509946
[TBL] [Abstract][Full Text] [Related]
26. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
27. [Significance of prospective follow-up cohort study in diagnosis and treatment of primary hepatic cancer among HBsAg carriers].
Lu P; Wang J; Wu Y
Zhonghua Yi Xue Za Zhi; 2001 Jul; 81(14):856-9. PubMed ID: 11702680
[TBL] [Abstract][Full Text] [Related]
28. Hepatitis B virus: pathogenesis and prevention of primary cancer of the liver.
Blumberg BS; London WT
Cancer; 1982 Dec; 50(11 Suppl):2657-65. PubMed ID: 6291743
[TBL] [Abstract][Full Text] [Related]
29. Primary hepatocellular carcinoma and viral hepatitis B and C infection in Bangladeshi subjects.
Zaman S; Khan M; Alam K; Williams R
J Trop Med Hyg; 1995 Feb; 98(1):64-8. PubMed ID: 7861482
[TBL] [Abstract][Full Text] [Related]
30. The relation between hepatitis B virus infection and hepatocellular carcinoma.
Popper H
Hepatogastroenterology; 1986 Feb; 33(1):2-5. PubMed ID: 3007316
[No Abstract] [Full Text] [Related]
31. Occult hepatitis B virus infection is associated with the development of hepatocellular carcinoma in chronic hepatitis C patients.
Squadrito G; Pollicino T; Cacciola I; Caccamo G; Villari D; La Masa T; Restuccia T; Cucinotta E; Scisca C; Magazzu D; Raimondo G
Cancer; 2006 Mar; 106(6):1326-30. PubMed ID: 16453330
[TBL] [Abstract][Full Text] [Related]
32. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
33. [HBs antigen: marker of the relation between hepatitis B virus and primary cancer of the liver: the situation in Brazzaville in 1984].
Gombe CM
IARC Sci Publ; 1984; (63):221-6. PubMed ID: 6100270
[TBL] [Abstract][Full Text] [Related]
34. Changes in liver histology as a "surrogate" end point of antiviral therapy for chronic HBV can predict progression to liver complications.
Hui CK; Leung N; Shek WH; Zhang HY; Luk JM; Poon RT; Lo CM; Fan ST; Lau GK;
J Clin Gastroenterol; 2008; 42(5):533-8. PubMed ID: 18344885
[TBL] [Abstract][Full Text] [Related]
35. Clinical features, biochemical parameters, and virological profiles of patients with hepatocellular carcinoma in Hong Kong.
Cheung TK; Lai CL; Wong BC; Fung J; Yuen MF
Aliment Pharmacol Ther; 2006 Aug; 24(4):573-83. PubMed ID: 16907890
[TBL] [Abstract][Full Text] [Related]
36. Seroprevalence of hepatitis B and C viral markers in patients with primary hepatocellular carcinoma in Singapore.
Khin LW; Teo CJ; Guan R
Singapore Med J; 1996 Oct; 37(5):492-6. PubMed ID: 9046201
[TBL] [Abstract][Full Text] [Related]
37. Possible contribution of prior hepatitis B virus infection to the development of hepatocellular carcinoma.
Tanaka H; Iwasaki Y; Nouso K; Kobayashi Y; Nakamura S; Matsumoto E; Toshikuni N; Kaneyoshi T; Ohsawa T; Takaguchi K; Fujio K; Senoh T; Ohnishi T; Sakaguchi K; Shiratori Y
J Gastroenterol Hepatol; 2005 Jun; 20(6):850-6. PubMed ID: 15946131
[TBL] [Abstract][Full Text] [Related]
38. Chronic liver diseases for the risk of hepatocellular carcinoma: a case-control study in Japan. Etiologic association of alcohol consumption, cigarette smoking and the development of chronic liver diseases.
Mukaiya M; Nishi M; Miyake H; Hirata K
Hepatogastroenterology; 1998; 45(24):2328-32. PubMed ID: 9951917
[TBL] [Abstract][Full Text] [Related]
39. [Hepatocellular carcinoma and hepatitis B virus].
Vargas Blasco V
Med Clin (Barc); 1983 Mar; 80(10):464-7. PubMed ID: 6304430
[No Abstract] [Full Text] [Related]
40. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
